燃石医学 BNR 深 沪
已收盘 10-02 16:00:00 美东时间
16.25
+0.260
+1.63%
华盛通- 最 高16.79
- 今 开16.36
- 成交量 1.53万股
- 最 低 16.05
- 昨 收 15.99
- 总市值 1.71亿
- 52周最高 41.72
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 6.79
- 委 比 0.50%
- 总股本 1054.63万
- 历史最高 397.50
- 量 比 0.32
- 振 幅 4.63%
- 历史最低 2.18
- 每 手 1
- 风险率 7.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Burning Rock Biotech Q3 non-GAAP EPS of RMB -$0.17, revenue of RMB $134.77M
Burning Rock Biotech press release (BNR): Non-GAAP EPS of RMB -$0.17. Revenue of RMB $134.77M (-9.3% Y/Y) from total business lines. Net loss widened to RMB 18.41M ($2.71M) for the quarter due to oper...
09-10 22:48
Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 100 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $19.862 million in sales this quarter. This is a 4.22 percent decrease over sales of $20.737 million ...
09-10 19:30
燃石医学（usBNR）8月25日收跌5.04%报9.80美元
经济观察网 燃石医学（美股代码usBNR）8月25日收盘报9.80美元，跌幅5.04%，此次下跌主因是利好出尽叠加极低流动性放大跌幅，并非基本面爆雷。 下跌原因...
08-26 04:39
Burning Rock Announces Founder’s Purchase of Its ADSs
Burning Rock Biotech founder Yusheng Han purchased 73,141 ADSs for $618,217.72, bringing his total to 145,874 ADSs across three trading windows, reflecting his confidence in the company's future. The company specializes in applying next-generation sequencing technology in precision oncology, focusing on therapy selection for late-stage cancer patients and early cancer detection. Han may continue to acquire shares depending on market conditions an...
07-02 11:19
泛生子15分钟走势图显示RSI超买且KDJ死叉
燃石医学15分钟级别行情触发多项看跌技术信号：其相对强弱指数（RSI）已突破70的超买阈值，随机指标（KDJ）于2026年6月29日11:45形成死叉。 当前该...
06-29 23:53
燃石医学15分钟线图显示MACD死叉与KDJ死叉
燃石生物医药（股票代码BNR）于2026年6月24日10时15分，其15分钟级别行情图同时触发MACD死叉与KDJ死叉，两类指标均为技术分析中常用的看跌动能转向...
06-24 22:30
Burning Rock Biotech Q1 EPS $(0.20), Same YoY, Sales $15.649M Down From $18.340M YoY
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is unchanged from the same period last year. The company reported $15.649 million in sales this quarter. This is a 14.67 percent
06-09 22:14
